Preclinical Assessment of IPH6501, a First-in-class IL2v-armed Tetraspecific NK Cell Engager Directed Against CD20 for R/R B-NHL, in Comparison with a CD20-targeting T Cell Engager.

Olivier Demaria, Marie Vetizou, Romain Remark,Laura Chiossone,Constance Vagne, Rachel Courtois,Caroline Denis, Aurelie Maguer, Francois Le Floch, Agnes Represa, Audrey Blanchard Alvarez, Laurent Gauthier, Sonia Quaratino,Carine Paturel,Eric Vivier

Journal of Clinical Oncology（2024）

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要